Buy ScripsAmerica

In: Tips

24 Sep 2012

Hi Everybody,

Great week last week. Thank you for all the nice emails from those of you that booked profits. Our Monday alert is a lot like our 49% winner from last week so pay close attention.

The company has a strong story and the chart looks strong as well.

Let’s get right to it.

Our alert for Monday is ScripsAmerica Inc., SCRC, and the stock closed Friday at 46 cents.

SCRC delivers pharmaceutical  solutions for pain, arthritis, prenatal, urinary, and hormonal replacement.

SCRC’s products are used by a wide range of end users across the healthcare industry, including physicians’ offices, retail pharmacies, long-term care sites, hospitals, and Government and home care agencies. A few of SCRC’s customers include  Cardinal Health, Curtis Pharmaceuticals, MedVet and the United States Veterans Administration.

SCRC has had some very positive developments over the last month that are helping generate exposure for the company and the stock.

SCRC recently secured $1 million dollars in funding for further development and distibution of it’s RapidMed product line.

SCRC recently announced the LOI to acquire Marlex Pharmaceuticals, Inc., a global pharmaceutical packaging company.

SCRC expects this acquisition to add an additional 10%-15% to it’s margins.

Last Friday RapiMed (a SCRC product) enjoyed a nice write up describing the product and the fact that SCRC has already delivered 6 million units to customers such as Walgreens.

A month ago, Elsevier, the world’s leading publisher of science and health information, profiled SCRC in its publication “The Tan Sheet”.

As we know, when it comes to OTC companies, the more exposure, the better.
SCRC showed an 84% increase in revenue from 2010 to 2011 to $5.9 million dollars.

SCRC showed its first  positive operating income  and net operating income from operations in the last quarter.  If it were not for accounting adjustments for prefered stock, SCRC would have shown a net profit.

When it comes to OTC pharma companies, that is a big deal. SCRC is moving in the right direction for sure.

From a technical standpoint, SCRC looks attractive as well.

We know that prior resistance often becomes the new support and that is exactly what we see with SCRC. The 40 cent area which was resistance is now support.

Another positive note is all the bottoming tails last week.

Bottoming tails tell us when the sellers try to push a stock down that the buyers come in strong pushing it higher.

Bottoming tails on support are a very positive sign.

Let’s recap:

– SCRC is in a strong Industry.
– SCRC has shown big growth in revenue.
– SCRC has been receiving positive press from industry publications
-SCRC has support and may be poised to breakout from here.

Get ready to book your profits with SCRC.

As always, do your own research, don’t chase gaps, use limit orders to enter positions, always use stop loss orders to protect your position, and take profits when you are in a position to do so.
Good Trading

Comment Form

*



Categories